Literature DB >> 20823883

The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise.

.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20823883     DOI： 10.1038/nm0910-981

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  34 in total

1.  Public health. Global HIV/AIDS policy in transition.

Authors:  John Bongaarts; Mead Over
Journal:  Science       Date:  2010-06-11       Impact factor: 47.728

2.  STEP study: disappointing, but not a failure.

Authors: 
Journal:  Lancet       Date:  2007-11-17       Impact factor: 79.321

Review 3.  Post-step modifications for research on HIV vaccines.

Authors:  Lawrence Corey; M Juliana McElrath; James G Kublin
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

Review 4.  Challenges for structure-based HIV vaccine design.

Authors:  William R Schief; Yih-En Andrew Ban; Leonidas Stamatatos
Journal:  Curr Opin HIV AIDS       Date:  2009-09       Impact factor: 4.283

5.  Fc receptor but not complement binding is important in antibody protection against HIV.

Authors:  Ann J Hessell; Lars Hangartner; Meredith Hunter; Carin E G Havenith; Frank J Beurskens; Joost M Bakker; Caroline M S Lanigan; Gary Landucci; Donald N Forthal; Paul W H I Parren; Preston A Marx; Dennis R Burton
Journal:  Nature       Date:  2007-09-06       Impact factor: 49.962

6.  Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge.

Authors:  Scott G Hansen; Cassandra Vieville; Nathan Whizin; Lia Coyne-Johnson; Don C Siess; Derek D Drummond; Alfred W Legasse; Michael K Axthelm; Kelli Oswald; Charles M Trubey; Michael Piatak; Jeffrey D Lifson; Jay A Nelson; Michael A Jarvis; Louis J Picker
Journal:  Nat Med       Date:  2009-02-15       Impact factor: 53.440

7.  Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses.

Authors:  Denis Gaucher; René Therrien; Nadia Kettaf; Bastian R Angermann; Geneviève Boucher; Abdelali Filali-Mouhim; Janice M Moser; Riyaz S Mehta; Donald R Drake; Erika Castro; Rama Akondy; Aline Rinfret; Bader Yassine-Diab; Elias A Said; Younes Chouikh; Mark J Cameron; Robert Clum; David Kelvin; Roland Somogyi; Larry D Greller; Robert S Balderas; Peter Wilkinson; Giuseppe Pantaleo; Jim Tartaglia; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  J Exp Med       Date:  2008-12-01       Impact factor: 14.307

Review 8.  The immune response during acute HIV-1 infection: clues for vaccine development.

Authors:  Andrew J McMichael; Persephone Borrow; Georgia D Tomaras; Nilu Goonetilleke; Barton F Haynes
Journal:  Nat Rev Immunol       Date:  2009-12-11       Impact factor: 53.106

9.  The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan.

Authors: 
Journal:  PLoS Med       Date:  2005-01-18       Impact factor: 11.069

10.  A prescription for human immunology.

Authors:  Mark M Davis
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745
View more
  19 in total

1.  Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells.

Authors:  Christopher A Todd; Kelli M Greene; Xuesong Yu; Daniel A Ozaki; Hongmei Gao; Yunda Huang; Maggie Wang; Gary Li; Ronald Brown; Blake Wood; M Patricia D'Souza; Peter Gilbert; David C Montefiori; Marcella Sarzotti-Kelsoe
Journal:  J Immunol Methods       Date:  2011-09-22       Impact factor: 2.303

Review 2.  The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors.

Authors:  Richard A Koup; Barney S Graham; Daniel C Douek
Journal:  Nat Rev Immunol       Date:  2010-12-17       Impact factor: 53.106

3.  Cloning, expression and preliminary crystallographic analysis of the equine infectious anaemia virus (EIAV) gp45 ectodomain.

Authors:  Pei Long Sun; Shu Xia Lv; Jian Hua Zhou; Xin Qi Liu
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-03-25

4.  Inhibition of HIV-1 integration in ex vivo-infected CD4 T cells from elite controllers.

Authors:  Maria J Buzon; Katherine Seiss; Robert Weiss; Abraham L Brass; Eric S Rosenberg; Florencia Pereyra; Xu G Yu; Mathias Lichterfeld
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

5.  Systems vaccinomics: the road ahead for vaccinology.

Authors:  Alan Bernstein; Bali Pulendran; Rino Rappuoli
Journal:  OMICS       Date:  2011-08-09

6.  Modeling the impact of RV144-like vaccines on HIV transmission.

Authors:  Catherine A Hankins; John W Glasser; Robert T Chen
Journal:  Vaccine       Date:  2011-07-14       Impact factor: 3.641

7.  Immune-mediated attenuation of HIV-1.

Authors:  Denis R Chopera; Jaclyn K Wright; Mark A Brockman; Zabrina L Brumme
Journal:  Future Virol       Date:  2011-08       Impact factor: 1.831

Review 8.  T-cell-inducing vaccines - what's the future.

Authors:  Sarah C Gilbert
Journal:  Immunology       Date:  2012-01       Impact factor: 7.397

9.  HIV-1 vaccines and adaptive trial designs.

Authors:  Lawrence Corey; Gary J Nabel; Carl Dieffenbach; Peter Gilbert; Barton F Haynes; Margaret Johnston; James Kublin; H Clifford Lane; Giuseppe Pantaleo; Louis J Picker; Anthony S Fauci
Journal:  Sci Transl Med       Date:  2011-04-20       Impact factor: 17.956

Review 10.  Organizing the HIV vaccine development effort.

Authors:  Yegor Voronin; William Snow
Journal:  Curr Opin HIV AIDS       Date:  2013-09       Impact factor: 4.283
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.